WO2009001805A1 - 新規なn結合型人工シアロ糖鎖含有ポリマーおよびその製造方法 - Google Patents
新規なn結合型人工シアロ糖鎖含有ポリマーおよびその製造方法 Download PDFInfo
- Publication number
- WO2009001805A1 WO2009001805A1 PCT/JP2008/061429 JP2008061429W WO2009001805A1 WO 2009001805 A1 WO2009001805 A1 WO 2009001805A1 JP 2008061429 W JP2008061429 W JP 2008061429W WO 2009001805 A1 WO2009001805 A1 WO 2009001805A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- sugar chain
- sialo
- containing polymer
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/48—Polymers modified by chemical after-treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/04—Preparatory processes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
- C08G69/10—Alpha-amino-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/40—Polyamides containing oxygen in the form of ether groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyamides (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009520586A JP5360497B2 (ja) | 2007-06-28 | 2008-06-24 | 新規なn結合型人工シアロ糖鎖含有ポリマーおよびその製造方法 |
US12/666,482 US8450441B2 (en) | 2007-06-28 | 2008-06-24 | Synthetic N-linked sialo-glycan-containing polymer and method for producing the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007-170079 | 2007-06-28 | ||
JP2007170079 | 2007-06-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009001805A1 true WO2009001805A1 (ja) | 2008-12-31 |
Family
ID=40185619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/061429 WO2009001805A1 (ja) | 2007-06-28 | 2008-06-24 | 新規なn結合型人工シアロ糖鎖含有ポリマーおよびその製造方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US8450441B2 (ja) |
JP (1) | JP5360497B2 (ja) |
WO (1) | WO2009001805A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011108471A1 (ja) * | 2010-03-04 | 2011-09-09 | 国立大学法人静岡大学 | ウィルス阻害剤 |
WO2014136931A1 (ja) * | 2013-03-08 | 2014-09-12 | 雪印メグミルク株式会社 | 感染防御剤 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021535150A (ja) * | 2018-09-04 | 2021-12-16 | エコール ポリテクニーク フェデラル デ ローザンヌ (イーピーエフエル) | 殺ウイルス性ナノ粒子及びインフルエンザウイルスに対するその使用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10310610A (ja) * | 1997-05-09 | 1998-11-24 | Snow Brand Milk Prod Co Ltd | シアリルラクトース結合ポリスチレン誘導体及びその用途 |
JP2002514186A (ja) * | 1996-10-02 | 2002-05-14 | シンテゾーメ ゲゼルシャフト フュア メッド.ビオフェミー ミット.ベシュレンクター.ハフツンク. | ウイルス性細胞接着阻害剤としての複合糖質 |
JP2003073397A (ja) * | 2001-08-30 | 2003-03-12 | Wakamoto Pharmaceut Co Ltd | 合成ムチン |
WO2007026669A1 (ja) * | 2005-09-02 | 2007-03-08 | Shizuoka Prefectural Universities Corporation | ウイルスレセプター糖鎖認識特異性の判別方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5079353A (en) * | 1987-12-02 | 1992-01-07 | Chembiomed, Ltd. | Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
US5742738A (en) * | 1988-05-20 | 1998-04-21 | John R. Koza | Simultaneous evolution of the architecture of a multi-part program to solve a problem using architecture altering operations |
CA2239296A1 (en) * | 1996-10-02 | 1998-04-09 | Syntesome Gesellschaft Fur Med. Biochemie M.B.H. | Glycoconjugates as virus cell adhesion inhibitors |
US6766348B1 (en) * | 1999-08-03 | 2004-07-20 | Worldcom, Inc. | Method and system for load-balanced data exchange in distributed network-based resource allocation |
US20030120824A1 (en) * | 2001-05-03 | 2003-06-26 | Scott Shattuck | System supporting object-oriented constructs in ECMAScript |
-
2008
- 2008-06-24 JP JP2009520586A patent/JP5360497B2/ja active Active
- 2008-06-24 WO PCT/JP2008/061429 patent/WO2009001805A1/ja active Application Filing
- 2008-06-24 US US12/666,482 patent/US8450441B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002514186A (ja) * | 1996-10-02 | 2002-05-14 | シンテゾーメ ゲゼルシャフト フュア メッド.ビオフェミー ミット.ベシュレンクター.ハフツンク. | ウイルス性細胞接着阻害剤としての複合糖質 |
JPH10310610A (ja) * | 1997-05-09 | 1998-11-24 | Snow Brand Milk Prod Co Ltd | シアリルラクトース結合ポリスチレン誘導体及びその用途 |
JP2003073397A (ja) * | 2001-08-30 | 2003-03-12 | Wakamoto Pharmaceut Co Ltd | 合成ムチン |
WO2007026669A1 (ja) * | 2005-09-02 | 2007-03-08 | Shizuoka Prefectural Universities Corporation | ウイルスレセプター糖鎖認識特異性の判別方法 |
Non-Patent Citations (1)
Title |
---|
OGATA ET AL.: "Chemoenzymatic synthesis of artificial glycopolypeptides containing multivalent sialyloligosaccharides with a gamma-polyglutamic acid backbone and their effect on inhibition of infection by influenza viruses", BIOORG. MED. CHEM., vol. 15, no. 3, 1 February 2007 (2007-02-01), pages 1383 - 1393, XP005823079 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011108471A1 (ja) * | 2010-03-04 | 2011-09-09 | 国立大学法人静岡大学 | ウィルス阻害剤 |
WO2014136931A1 (ja) * | 2013-03-08 | 2014-09-12 | 雪印メグミルク株式会社 | 感染防御剤 |
JP2014172862A (ja) * | 2013-03-08 | 2014-09-22 | Snow Brand Milk Products Co Ltd | 感染予防剤 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2009001805A1 (ja) | 2010-08-26 |
US20100168366A1 (en) | 2010-07-01 |
JP5360497B2 (ja) | 2013-12-04 |
US8450441B2 (en) | 2013-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007079186A3 (en) | 1, 3-oxazolidin-2-one derivatives useful as cetp inhibitors | |
PT2310356E (pt) | Derivados de adamantildiamida e a sua utilização | |
WO2007113223A3 (en) | Immunogenic composition | |
WO2007125547A3 (en) | Novel process for statins and its pharmaceutically acceptable salts thereof | |
WO2010042397A3 (en) | Molecular sieve ssz-82 composition of matter and synthesis thereof | |
WO2009043027A3 (en) | Multi-armed forms of activated polyoxazoline and methods of synthesis thereof | |
AR062504A1 (es) | Procedimientos para preparar acidos d,l-2hidroxi-4-alquiltiobutiricos | |
AU2008255733A8 (en) | Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity | |
UA100367C2 (uk) | Спосіб одержання мемантину і його гідрохлориду | |
WO2012015681A3 (en) | Drug-ligand conjugates, synthesis thereof, and intermediates thereto | |
WO2013098802A3 (en) | Solid phase peptide synthesis via side chain attachment of hydroxyl amino acids | |
MX2011007543A (es) | Compuesto ciclico que contiene heteroatomos. | |
MX2009003823A (es) | Nueva difenilazetidinona sustituida con acido piperazina-1-sulfonico y que tiene propiedades farmacologicas mejoradas. | |
UA95095C2 (en) | 11 beta-hydroxyandrosta-1,4-diene-3-ones | |
WO2009154754A3 (en) | Synthesis of deuterated morpholine derivatives | |
AU2015275248B2 (en) | Legumain activated doxorubicin derivative as well as preparation method and application thereof | |
WO2010059297A3 (en) | Processes using molecular sieve ssz-82 | |
WO2008136512A1 (ja) | 光学異性体用分離剤 | |
WO2011103610A3 (de) | Pflanzenschutzmittel | |
WO2009001805A1 (ja) | 新規なn結合型人工シアロ糖鎖含有ポリマーおよびその製造方法 | |
WO2010120058A3 (ko) | 생체 분자 표지를 위한 신규 시아닌 화합물 및 그 제조방법 | |
MX2012004835A (es) | Derivados de espirolactama y usos de los mismos. | |
WO2006117800A3 (en) | Novel 3, 4-propylenedioxythiophene derivatives with pendant functional groups | |
HRP20110568T1 (en) | Process for the preparation of agomelatin | |
WO2008024277A3 (en) | Kw-3902 conjugates that do not cross the blood-brain barrier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08777534 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2009520586 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12666482 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08777534 Country of ref document: EP Kind code of ref document: A1 |